Alerts will be sent to your verified email
Verify Email
QUESTLAB
|
Quest Laboratories
|
Nectar Lifesciences
|
Oxygenta Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
27.48 % | 0.55 % | 16.56 % |
|
5yr average Equity Multiplier
|
2.66 | 2.12 | -1.71 |
|
5yr Average Asset Turnover Ratio
|
1.38 | 0.73 | 1.26 |
|
5yr Avg Net Profit Margin
|
8.5 % | -2.27 % | -10.07 % |
|
Price to Book
|
2.01 | 0.27 | 0.0 |
|
P/E
|
13.31 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
100.68 Days | 88.68 Days | -21.7 Days |
|
Inventory Days
|
35.64 Days | 136.85 Days | 80.38 Days |
|
Days Receivable
|
95.62 Days | 69.3 Days | 20.8 Days |
|
Days Payable
|
124.41 Days | 116.07 Days | 154.17 Days |
|
5yr Average Interest Coverage Ratio
|
15.83 | 0.46 | -3.16 |
|
5yr Avg ROCE
|
36.4 % | 3.29 % | -3.19 % |
|
5yr Avg Operating Profit Margin
|
12.5 % | 5.36 % | -9.3 % |
|
5 yr average Debt to Equity
|
0.33 | 0.71 | -1.91 |
|
5yr CAGR Net Profit
|
83.07 % | 9.19 % | n/a |
|
5yr Average Return on Assets
|
10.79 % | -1.73 % | -6.87 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
66.78 % | 44.91 % | 55.93 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.95 % | -10.89 % | 43.6 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -0.04 % |
|
Quest Laboratories
|
Nectar Lifesciences
|
Oxygenta Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|